A citation-based method for searching scientific literature

Giacomo Montagna, Monica Morrow. Clin Breast Cancer 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Patient Perspectives on Treatment Options for Older Women With Hormone Receptor-Positive Breast Cancer: A Qualitative Study.
Ton Wang, Nicole Mott, Jacquelyn Miller, Nicholas L Berlin, Sarah Hawley, Reshma Jagsi, Lesly A Dossett. JAMA Netw Open 2020
17
100

Decreasing Recurrence Rates for Ductal Carcinoma In Situ: Analysis of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years.
Preeti Subhedar, Cristina Olcese, Sujata Patil, Monica Morrow, Kimberly J Van Zee. Ann Surg Oncol 2015
35
100

Standard for breast conservation therapy in the management of invasive breast carcinoma.
Monica Morrow, Eric A Strom, Lawrence W Bassett, D David Dershaw, Barbara Fowble, Armando Giuliano, Jay R Harris, Frances O'Malley, Stuart J Schnitt, S Eva Singletary,[...]. CA Cancer J Clin 2002
219
100

Patient involvement in surgery treatment decisions for breast cancer.
Steven J Katz, Paula M Lantz, Nancy K Janz, Angela Fagerlin, Kendra Schwartz, Lihua Liu, Dennis Deapen, Barbara Salem, Indu Lakhani, Monica Morrow. J Clin Oncol 2005
247
100

Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline.
Nadine M Tung, Judy C Boughey, Lori J Pierce, Mark E Robson, Isabelle Bedrosian, Jill R Dietz, Anthony Dragun, Judith Balmana Gelpi, Erin W Hofstatter, Claudine J Isaacs,[...]. J Clin Oncol 2020
107
100

Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial.
Guido Henke, Michael Knauer, Karin Ribi, Stefanie Hayoz, Marie-Aline Gérard, Thomas Ruhstaller, Daniel R Zwahlen, Simone Muenst, Markus Ackerknecht, Hanne Hawle,[...]. Trials 2018
45
100

Is sentinel node biopsy necessary in conservatively treated DCIS?
Thomas B Julian, Stephanie R Land, Virginie Fourchotte, Sarah R Haile, Edwin R Fisher, Eleftherios P Mamounas, Joseph P Costantino, Norman Wolmark. Ann Surg Oncol 2007
28
100

DUCHESS: an evaluation of the ductal carcinoma in situ score for decisions on radiotherapy in patients with low/intermediate-risk DCIS.
Eileen Rakovitch, Sameer Parpia, Anne Koch, Laval Grimard, Hany Soliman, Christiaan Stevens, Francisco Perera, Iwa Kong, Senti Senthelal, Margaret Anthes,[...]. Breast Cancer Res Treat 2021
2
100

Impact of 21-Gene Breast Cancer Assay on Treatment Decision for Patients with T1-T3, N0-N1, Estrogen Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE Study.
Maria Vittoria Dieci, Valentina Guarneri, Fable Zustovich, Marta Mion, Paolo Morandi, Emilio Bria, Laura Merlini, Pierluigi Bullian, Cristina Oliani, Stefania Gori,[...]. Oncologist 2019
14
100

Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
Steven A Narod, Javaid Iqbal, Vasily Giannakeas, Victoria Sopik, Ping Sun. JAMA Oncol 2015
350
100

Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline.
Larissa A Korde, Mark R Somerfield, Lisa A Carey, Jennie R Crews, Neelima Denduluri, E Shelley Hwang, Seema A Khan, Sibylle Loibl, Elizabeth A Morris, Alejandra Perez,[...]. J Clin Oncol 2021
153
100

Trends on Axillary Surgery in Nondistant Metastatic Breast Cancer Patients Treated Between 2011 and 2015: A Dutch Population-based Study in the ACOSOG-Z0011 and AMAROS Era.
Ingrid G M Poodt, Pauline E R Spronk, Guusje Vugts, Thijs van Dalen, M T F D Vrancken Peeters, Marjolijn L Rots, Anne Kuijer, Grard A P Nieuwenhuijzen, Robert-Jan Schipper. Ann Surg 2018
42
100

Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.
Ann Partridge, Kristie Adloff, Emily Blood, E Claire Dees, Carolyn Kaelin, Mehra Golshan, Jennifer Ligibel, Janet S de Moor, Jane Weeks, Karen Emmons,[...]. J Natl Cancer Inst 2008
129
100

Sentinel Node Biopsy Should Not be Routine in Older Patients with ER-Positive HER2-Negative Breast Cancer Who Are Willing and Able to Take Hormone Therapy.
Elaine McKevitt, Rona Cheifetz, Kimberly DeVries, Alison Laws, Rebecca Warburton, Lovedeep Gondara, Caroline Lohrisch, Alan Nichol. Ann Surg Oncol 2021
12
100

Contralateral prophylactic mastectomy in breast cancer: what to discuss with patients.
Giacomo Montagna, Monica Morrow. Expert Rev Anticancer Ther 2020
6
100


Breast cancer: from "maximum tolerable" to "minimum effective" treatment.
Umberto Veronesi, Vaia Stafyla, Alberto Luini, Paolo Veronesi. Front Oncol 2012
30
100

Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
Sara M Tolaney, Hao Guo, Sonia Pernas, William T Barry, Deborah A Dillon, Lauren Ritterhouse, Bryan P Schneider, Fei Shen, Kit Fuhrman, Michele Baltay,[...]. J Clin Oncol 2019
142
100

Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343.
Kevin S Hughes, Lauren A Schnaper, Jennifer R Bellon, Constance T Cirrincione, Donald A Berry, Beryl McCormick, Hyman B Muss, Barbara L Smith, Clifford A Hudis, Eric P Winer,[...]. J Clin Oncol 2013
699
100

Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast.
U Veronesi, R Saccozzi, M Del Vecchio, A Banfi, C Clemente, M De Lena, G Gallus, M Greco, A Luini, E Marubini,[...]. N Engl J Med 1981
100

Selecting Node-Positive Patients for Axillary Downstaging with Neoadjuvant Chemotherapy.
Giacomo Montagna, Anita Mamtani, Andrea Knezevic, Edi Brogi, Andrea V Barrio, Monica Morrow. Ann Surg Oncol 2020
31
100

Women with Low-Risk DCIS Eligible for the LORIS Trial After Complete Surgical Excision: How Low Is Their Risk After Standard Therapy?
Melissa Pilewskie, Cristina Olcese, Sujata Patil, Kimberly J Van Zee. Ann Surg Oncol 2016
25
100

Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness.
H Gilbert Welch, Philip C Prorok, A James O'Malley, Barnett S Kramer. N Engl J Med 2016
323
100

Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public.
M L Slevin, L Stubbs, H J Plant, P Wilson, W M Gregory, P J Armes, S M Downer. BMJ 1990
592
100

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.
Jack Cuzick, Ivana Sestak, Sarah E Pinder, Ian O Ellis, Sharon Forsyth, Nigel J Bundred, John F Forbes, Hugh Bishop, Ian S Fentiman, William D George. Lancet Oncol 2011
337
100

Nationwide trends in mastectomy for early-stage breast cancer.
Kristy L Kummerow, Liping Du, David F Penson, Yu Shyr, Mary A Hooks. JAMA Surg 2015
410
100

What is an adequate margin for breast-conserving surgery? Surgeon attitudes and correlates.
Michelle Azu, Paul Abrahamse, Steven J Katz, Reshma Jagsi, Monica Morrow. Ann Surg Oncol 2010
142
100

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.
Joseph A Sparano, Robert J Gray, Peter M Ravdin, Della F Makower, Kathleen I Pritchard, Kathy S Albain, Daniel F Hayes, Charles E Geyer, Elizabeth C Dees, Matthew P Goetz,[...]. N Engl J Med 2019
230
100

Controversial Areas in Axillary Staging: Are We Following the Guidelines?
Ava Armani, Sasha Douglas, Swati Kulkarni, Anne Wallace, Sarah Blair. Ann Surg Oncol 2021
5
100


Is sentinel lymph node biopsy indicated in patients with a diagnosis of ductal carcinoma in situ? A systematic literature review and meta-analysis.
Hiba El Hage Chehade, Hannah Headon, Umar Wazir, Houssam Abtar, Abdul Kasem, Kefah Mokbel. Am J Surg 2017
25
100

Survival benefit needed to undergo chemotherapy: Patient and physician preferences.
Ines Vaz-Luis, Anne O'Neill, Karen Sepucha, Kathy D Miller, Emily Baker, Chau T Dang, Donald W Northfelt, Eric P Winer, George W Sledge, Bryan Schneider,[...]. Cancer 2017
12
100

Recurrence risk perception and quality of life following treatment of breast cancer.
Sarah T Hawley, Nancy K Janz, Kent A Griffith, Reshma Jagsi, Christopher R Friese, Allison W Kurian, Ann S Hamilton, Kevin C Ward, Monica Morrow, Lauren P Wallner,[...]. Breast Cancer Res Treat 2017
39
100

The Feasibility of Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial.
Kari M Rosenkranz, Karla Ballman, Linda McCall, Charlotte Kubicky, Laurie Cuttino, Huong Le-Petross, Kelly K Hunt, Armando Giuliano, Kimberly J Van Zee, Bruce Haffty,[...]. Ann Surg Oncol 2018
25
100

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.
Norikazu Masuda, Soo-Jung Lee, Shoichiro Ohtani, Young-Hyuck Im, Eun-Sook Lee, Isao Yokota, Katsumasa Kuroi, Seock-Ah Im, Byeong-Woo Park, Sung-Bae Kim,[...]. N Engl J Med 2017
757
100




Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08).
L M van Roozendaal, M L G Vane, T van Dalen, J A van der Hage, L J A Strobbe, L J Boersma, S C Linn, M B I Lobbes, P M P Poortmans, V C G Tjan-Heijnen,[...]. BMC Cancer 2017
53
100




A Systematic Approach to Discussing Active Surveillance with Patients with Low-risk Prostate Cancer.
Behfar Ehdaie, Melissa Assel, Nicole Benfante, Deepak Malhotra, Andrew Vickers. Eur Urol 2017
25
100

A population-based study of the fractionation of postlumpectomy breast radiation therapy.
Allison Ashworth, Weidong Kong, Timothy Whelan, William J Mackillop. Int J Radiat Oncol Biol Phys 2013
57
100

Effectiveness of Breast-Conserving Surgery and 3-Dimensional Conformal Partial Breast Reirradiation for Recurrence of Breast Cancer in the Ipsilateral Breast: The NRG Oncology/RTOG 1014 Phase 2 Clinical Trial.
Douglas W Arthur, Kathryn A Winter, Henry M Kuerer, Bruce Haffty, Laurie Cuttino, Dorin A Todor, Pramila Rani Anne, Penny Anderson, Wendy A Woodward, Beryl McCormick,[...]. JAMA Oncol 2020
35
100

Present clinical practice of breast cancer radiotherapy in Italy: a nationwide survey by the Italian Society of Radiotherapy and Clinical Oncology (AIRO) Breast Group.
Fabiana Gregucci, Alessandra Fozza, Sara Falivene, Daniela Smaniotto, Anna Morra, Antonino Daidone, Raffaele Barbara, Antonella Ciabattoni. Radiol Med 2020
20
100

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
Lawrence J Solin, Robert Gray, Frederick L Baehner, Steven M Butler, Lorie L Hughes, Carl Yoshizawa, Diana B Cherbavaz, Steven Shak, David L Page, George W Sledge,[...]. J Natl Cancer Inst 2013
332
100

Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial From China.
Shu-Lian Wang, Hui Fang, Chen Hu, Yong-Wen Song, Wei-Hu Wang, Jing Jin, Yue-Ping Liu, Hua Ren, Juan Liu, Gao-Feng Li,[...]. J Clin Oncol 2020
27
100

Long-term outcomes of ductal carcinoma in situ of the breast: a systematic review, meta-analysis and meta-regression analysis.
Kirsty E Stuart, Nehmat Houssami, Richard Taylor, Andrew Hayen, John Boyages. BMC Cancer 2015
50
100

Patterns and correlates of local therapy for women with ductal carcinoma-in-situ.
Steven J Katz, Paula M Lantz, Nancy K Janz, Angela Fagerlin, Kendra Schwartz, Lihua Liu, Dennis Deapen, Barbara Salem, Indu Lakhani, Monica Morrow. J Clin Oncol 2005
78
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.